Stay updated with breaking news from Bateman Horne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
28.02.2024 - ATLANTA, Ga., Feb. 28, 2024 (GLOBE NEWSWIRE) - Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including ... Seite 1
ATLANTA, Sept. 18, 2023 -- Virios Therapeutics, Inc. , a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases such as...
Virios Therapeutics, Inc. (NASDAQ:VIRI) Q2 2023 Earnings Call Transcript August 10, 2023 Virios Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07. Operator: Good day, and welcome to the Virios Therapeutics, Inc. Q2 2023 Earnings Update. At this time, all participants have been placed in a listen-only mode. Please be […]
This Medical News article discusses challenges to treatment of post–COVID-19 condition in primary care.
Speakers at a recent scientific ME/CFS conference reported new data linking the three conditions. New ICD-10 codes will help clinicians document them.